Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02448173
Recruitment Status : Recruiting
First Posted : May 19, 2015
Last Update Posted : July 27, 2015
Sponsor:
Information provided by (Responsible Party):
Vaccinogen Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2020
Estimated Study Completion Date : July 2022